ArticleJournal for immunotherapy of cancer2024

Afatinib boosts CAR-T cell antitumor therapeutic efficacy via metabolism and fate reprogramming.

Yueyu Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.